Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
帕博利珠单抗联合化疗的II期临床试验揭示了转移性三阴性乳腺癌放射学反应的不同转录组特征
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1349
Wilkerson, Avia D; Parthasarathy, Prerana Bangalore; Stabellini, Nickolas; Mitchell, Carley; Pavicic, Paul G Jr; Fu, Pingfu; Rupani, Amit; Husic, Hana; Rayman, Patricia A; Swaidani, Shadi; Abraham, Jame; Budd, G Thomas; Moore, Halle; Al-Hilli, Zahraa; Ko, Jennifer S; Baar, Joseph; Chan, Timothy A; Alban, Tyler; Diaz-Montero, C Marcela; Montero, Alberto J